Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam
Patients with the EGFR-G719X mutation achieve significantly better TTF and OS benefits than those with other uncommon EGFR mutations.
Authors
- Le Huy Trinh
- Ha Thanh Vu (ORCID: https://orcid.org/0009-0007-3585-8460)
- Văn Luận Phạm (ORCID: https://orcid.org/0000-0002-2291-1054)
- Minh‐Hai Nguyen (ORCID: https://orcid.org/0000-0002-5809-6813)
- Lê Anh Tuấn (ORCID: https://orcid.org/0000-0002-0770-4671)
- Thi Bich Phuong Nguyen (ORCID: https://orcid.org/0000-0001-9685-4745)
- Thi Thai Hoa Nguyen
- Cong Minh Truong (ORCID: https://orcid.org/0000-0003-3953-6729)
- Thi Oanh Nguyen (ORCID: https://orcid.org/0000-0001-6295-3809)
- Van Thai Pham (ORCID: https://orcid.org/0009-0005-3073-8406)
- Kien Hung (ORCID: https://orcid.org/0000-0001-6059-7046)
- Tuan Khoi Nguyen
- Thi Thuy Hang Nguyen (ORCID: https://orcid.org/0000-0003-4003-5286)
- Thị Anh Thư Hoàng
- Cẩm Phương Phạm (ORCID: https://orcid.org/0000-0002-4342-0959)
- Tran Minh Chau Pham
- Dac Nhan Tam Nguyen
- Văn Khiêm Đặng
- Đình Thy Hảo Vương (ORCID: https://orcid.org/0000-0001-8313-5688)
- Hoang Gia Nguyen
Institutions
- Vietnam National University, Hanoi (VN)
- Hanoi Medical University (VN)
- Cho Ray Hospital (VN)
- HCMC Hospital of Dermato Venereology (VN)
- Vietnam National Children's Hospital (VN)
- VinUniversity (VN)
- Bạch Mai Hospital (VN)
- 108 Military Central Hospital (VN)
- Hanoi Lung Hospital (VN)
Publication Details
- Journal
- Therapeutic Advances in Respiratory Disease
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17534666251341747
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00